bowel cancer immunotherapy News

Latest Articles

• UCL NEOPRISM-CRC Trial Reports Zero Relapses for Bowel Cancer Patients Using Pre-Op Immunotherapy

  Published: Apr 21, 2026

  Section: Medical News

  Long-term results from the NEOPRISM-CRC clinical trial show that a short course of pembrolizumab immunotherapy before surgery has kept 100% of high-risk bowel cancer patients cance...